Study Review – RE-DUAL PCI, Atrial Fibrillation

This review summarises and discusses the methods and results of the Randomised Evaluation of Dual Antithrombotic Therapy with Dabigatran after percutaneous coronary intervention (PCI) in Atrial Fibrillation (the RE-DUAL PCI) study.

Independent expert commentary provided by Dr Allison Morton, a cardiologist specialist at HeartCare Bunbury, WA.

Please login below to download this issue (PDF)